|
|
(29 intermediate revisions by 5 users not shown) |
Line 1: |
Line 1: |
| == Chart == | | ==Background== |
| | *STD Prevalence: HPV> HSV-2 > Trichomonas > Chlamydia > [[HIV]] > HBV > Gonorrhea > Syphillis |
| | *STD New infections: HPV > Chlamydia > Trichomonas > Gonorrhea > HSV-2 > Syphillis > [[HIV]] > HBV <ref>[http://www.cdc.gov/std/stats/sti-estimates-fact-sheet-feb-2013.pdf CDC: STI Fact sheet 2013]</ref> |
| | *It is important to treat sexual partners for all STDs |
| | **See [[Expedited Partner Therapy]] |
|
| |
|
| {| style="border-right: medium none; border-top: medium none; border-left: medium none; border-bottom: medium none; border-collapse: collapse" border="1"
| | ==Visual Diagnosis== |
| |-
| | {{Genital images male}} |
| | style="border-right: windowtext 0.5pt solid; padding-right: 5.4pt; border-top: windowtext 0.5pt solid; padding-left: 5.4pt; padding-bottom: 0in; border-left: windowtext 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: windowtext 0.5pt solid" valign="top" width="82" |
| | {{Genital images female}} |
| '''Disorder'''
| |
|
| |
|
| | style="border-right: windowtext 0.5pt solid; padding-right: 5.4pt; border-top: windowtext 0.5pt solid; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: windowtext 0.5pt solid" valign="top" width="108" |
| | ==[[Bacterial Vaginosis]]== |
| '''Clinical'''
| | {{BV Antibiotics}} |
|
| |
|
| | style="border-right: windowtext 0.5pt solid; padding-right: 5.4pt; border-top: windowtext 0.5pt solid; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: windowtext 0.5pt solid" valign="top" width="162" |
| |
| '''1<sup>st</sup> line'''
| |
|
| |
|
| | style="border-right: windowtext 0.5pt solid; padding-right: 5.4pt; border-top: windowtext 0.5pt solid; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: windowtext 0.5pt solid" valign="top" width="176" |
| | ==[[Cervicitis]]== |
| '''Alternative'''
| | {{Cervicitis Urethritis Antibiotics}} |
|
| |
|
| | style="border-right: windowtext 0.5pt solid; padding-right: 5.4pt; border-top: windowtext 0.5pt solid; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: windowtext 0.5pt solid" valign="top" width="90" |
| | ==[[Epididymitis]]/[[Epididymorchitis]]== |
| '''Partner'''
| | {{Epididymitis antibiotics}} |
|
| |
|
| | style="border-right: windowtext 0.5pt solid; padding-right: 5.4pt; border-top: windowtext 0.5pt solid; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: windowtext 0.5pt solid" valign="top" width="108" |
| |
| '''In Pregnancy'''
| |
|
| |
|
| |-
| | ==[[GC]]/[[Chlamydia]] Conjunctivitis== |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" |
| |
| ''N. Gonorrhea''
| |
|
| |
|
| Urethritis/
| | {{GC Conjunctivitis Treatment}} |
|
| |
|
| Cervicitis
| |
|
| |
|
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | | | ==[[HSV|Herpes]]== |
| M: urethritis with d/c or simply dysuria;can be asymptomatic
| | {{Herpes antiviral treatment}} |
|
| |
|
| F: purulent discharge; can be asymptomatic
| |
|
| |
|
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" |
| |
| Ceftriaxone 250mg IM
| |
|
| |
|
| OR
| | ==[[Lymphogranuloma Venereum]]== |
| | {{LGV antibiotics}} |
|
| |
|
| Cefixime (Suprax) 400mg po x1
| |
|
| |
|
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" |
| | ==[[Proctitis]]== |
| Spectinomycin 2g IM x 1
| | {{Proctitis antibiotics}} |
|
| |
|
| OR
| |
|
| |
|
| Azithromycin 2g po x 1
| | ==[[PID]]== |
| | {{PID antibiotics}} |
|
| |
|
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" |
| |
| Treat and abstinence x 7d after both treated
| |
|
| |
|
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" |
| | ==[[Syphilis]]== |
| CTX 250mg IM x 1
| | ===Early Stage=== |
| | This is classified as primary, secondary, and early latent syphilis less than one year. |
|
| |
|
| |-
| | Treatment Options: |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" |
| |
| ''N. Gonorrhea''
| |
|
| |
|
| [[Gonorrheal Conjunctivitis|Conjunctivitis]]
| | {{Early Syphilis Treatment}} |
|
| |
|
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" |
| | ===Late Stage=== |
| 2-5d after birth
| | Late stage is greater than one year duration, presence of gummas, or cardiovascular disease |
|
| |
|
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" |
| | Treatment Options: |
| Erythromycin ophthalmic 0.5% x1
| |
|
| |
|
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" |
| | {{Late Syphilis Treatment}} |
| Tetracycline ophthalmic 1% x1
| | ===Neurosyphilis=== |
| | There are 3 Major options with none showing greater efficacy than others: |
|
| |
|
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" | <br>
| | {{Neurosyphilis Treatment }} |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | <br>
| |
| |-
| |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" |
| |
| ''N. Gonorrhea''
| |
|
| |
|
| Disseminated
| | *Desensitization to the penicillin allergy is still the preferred method of treatment for patients with early and late stage disease (especially during pregnancy) |
|
| |
|
| (DGI)
| | ===Pregnancy=== |
| | *[[Penicillin]], dosage depends on stage <ref>Mackay G. Chapter 43. Sexually Transmitted Diseases & Pelvic Infections. In:DeCherney AH, Nathan L, Laufer N, Roman AS. eds. CURRENT Diagnosis & Treatment: Obstetrics & Gynecology, 11e. New York, NY: McGraw-Hill; 2013</ref> |
|
| |
|
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" |
| |
| Petechial, pustular acral skin lesions,
| |
|
| |
|
| Asymmetrical arthralgias, tenosynovitis,
| | ==[[Trichomonas vaginalis]]== |
| | {{Trichomonas antibiotics}} |
|
| |
|
| Septic arthritis
| |
|
| |
|
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" |
| | ==[[Urethritis]] (male)== |
| CTX 1g IM/IV q24
| | {{Male urethritis treatment}} |
| | |
| -continue x24-48h until improvement
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" |
| |
| Cefotax 1g IV q8
| |
| | |
| Spectinomycin 2g IV q12
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" | <br>
| |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | <br>
| |
| |-
| |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" |
| |
| ''Chlamydia Trachomatis''
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" |
| |
| M: urethritis with d/c or simply dysuria; can be asymptomatic
| |
| | |
| F: purulent discharge or cervical bleeding; can be asymptomatic
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" |
| |
| Azithromycin 1g po x1
| |
| | |
| OR
| |
| | |
| Doxycycline 100mg po bid x 7d
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" |
| |
| Erythromycin base 500mg po qid x 7d OR
| |
| | |
| Oflox 300mg po bid x 7d
| |
| | |
| OR
| |
| | |
| Levoflox 500mg po qd x 7days
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" |
| |
| Treat and abstinence x 7d after both treated
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" |
| |
| Azithromycin 1g po x1 or
| |
| | |
| Amoxicillin 500mg po tid x 7d
| |
| | |
| Or
| |
| | |
| Erythro
| |
| | |
| |-
| |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" |
| |
| ''Chlamydia''
| |
| | |
| ''Trachomatis''
| |
| | |
| Conjunctivitis
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" |
| |
| 5-12d after birth; silver nitrate ophthalmic only rx gonorrhea
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" |
| |
| Erythromycin base 50mg/kg/day PO / 4 doses x14days
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" | <br>
| |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" | <br>
| |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | <br>
| |
| |-
| |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" |
| |
| ''Chlamydia Trachomatis''
| |
| | |
| Pneumonia
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" |
| |
| 1-3months; afebrile, staccato cough with diffuse infiltrates on CXR; peripheral eosinophilia
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" |
| |
| Erythromycin base 50mg/kg/day po / 4 doses x14days
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" | <br>
| |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" | <br>
| |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | <br>
| |
| |-
| |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" |
| |
| ''Trichamonas vaginalis''
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" |
| |
| White, thick discharge
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" |
| |
| Metronidazole 2g po x 1
| |
| | |
| OR
| |
| | |
| Tinidazole 2g po x 1
| |
| | |
| PLUS
| |
| | |
| Azithro 1g po x 1
| |
| | |
| -intravag cream not recommended
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" |
| |
| Metronidazole 500mg bid for 7days; 1-2g po qday x 7d if recurrence
| |
| | |
| OR
| |
| | |
| Topical clotrimazole for metronidazole allergy– not as effective
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" |
| |
| Metronidazole 2g po x 1
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" |
| |
| Rx only if symptomatic but rx partner
| |
| | |
| 1<sup>st</sup> trimester, Clotrimazole 100mg hs for 7days
| |
| | |
| After 1<sup>st</sup> trimester,<span> </span>Metronidazole 2g po x 1
| |
| | |
| |-
| |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" |
| |
| Bacterial Vaginosis
| |
| | |
| ''Lactobacillus''
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" |
| |
| White, fishy discharge
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" |
| |
| Metronidazole 500mg po bid for 7d
| |
| | |
| OR
| |
| | |
| 0.75% Metronidazole gel (one full applicator 5g) intravaginal qd for 5d
| |
| | |
| OR
| |
| | |
| 2% Clindamycin cream 5g qd for 7d
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" |
| |
| Clindamycin 300mg po bid for 7d (recurrence)
| |
| | |
| OR
| |
| | |
| Clindamycin ovules 100mg intravaginally qhs x 3d
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" |
| |
| Exam for STD
| |
| | |
| No rx if nl
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" |
| |
| 1<sup>st</sup> trimester, metronidazole 250mg po tid x7d
| |
| | |
| After 1<sup>st</sup> trimester, 500mg po bid for 7days or 250mg po tid x7d or Clinda 300mg po bid x 7d
| |
| | |
| |-
| |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" |
| |
| Candidiasis
| |
| | |
| (''Candida albicans''<span style="font-style: normal">)</span>
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" |
| |
| Cottage cheese;
| |
| | |
| DM or immunocompromised
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" |
| |
| Butoconazole 2% cream 5g intravaginally for 3d
| |
| | |
| OR
| |
| | |
| Butaconazole-sustained 2% intravag x1
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" |
| |
| Clotrimazole 1%<span> </span>5g cream intravaginally for 7-14d (OTC)
| |
| | |
| OR
| |
| | |
| Clotrimazole 100mg intravag tablet x 7d
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" |
| |
| Candicidal cream if dermatitis present
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" |
| |
| Avoid fluconazole and ketoconazole.
| |
| | |
| Rx with cream for 7d
| |
| | |
| |-
| |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" |
| |
| Chancroid
| |
| | |
| (''H. ducreyi''<span style="font-style: normal">)</span>
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" |
| |
| Painful ulcers with suppurative LAD
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" |
| |
| Azithromycin 1g PO x 1
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" |
| |
| CTX 250mg IM x1
| |
| | |
| Cipro 500mg PO bid x 3days
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" |
| |
| See CDC
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" |
| |
| CTX
| |
| | |
| |-
| |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" |
| |
| Granuloma Inguinale<span> </span>(Donvanosis)
| |
| | |
| ''Klebsiella granulomatis''
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" |
| |
| Painless lesions without LAD
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" |
| |
| Doxycycline 100mg PO BID x 3wks and until all lesions heald
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" |
| |
| Aizthromycin 1g po q week
| |
| | |
| Ciproflox 750mg PO bid x 3 weeks
| |
| | |
| Bactrim DS 1tab PO BID x 3 wks
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" |
| |
| same
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" |
| |
| Erythromycin base 500mg po qid x 3wks
| |
| | |
| |-
| |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" |
| |
| Lymphogranuloma Venereum (LGV)
| |
| | |
| ''C. trach'' <span style="font-style: normal">serovars L1-L3</span>
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" |
| |
| Tender, unilateral LAD; can lead to proctitis, fistulas
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" |
| |
| Doxycycline 100mg po bid x 3 weeks
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" |
| |
| Erythromycin base 500mg po qid x 3wks
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" |
| |
| Treat within 60days of exposure with standard Chlamydia Rx
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" |
| |
| Erythromycin base 500mg po qid x 3wks
| |
| | |
| |-
| |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" |
| |
| Chancre-
| |
| | |
| Primary
| |
| | |
| Syphilis
| |
| | |
| (''T. pallidum''<span style="font-style: normal">)</span>
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" |
| |
| Painless ulcer, chancre
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" |
| |
| Benzathine Penicillin G 1.2million U IM x1
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" |
| |
| Doxycycline 100mg po bid x 14d
| |
| | |
| Tetracycline 500mg po qid x 14d
| |
| | |
| CTX 1g IM/IV x 8-10d
| |
| | |
| Azithromycin 2g po x 1?
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" |
| |
| See CDC
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" |
| |
| Penicillin; if allergic desensitize
| |
| | |
| |-
| |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" |
| |
| Secondary Syphilis
| |
| | |
| (''T. pallidum''<span style="font-style: normal">)</span>
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" |
| |
| Skin rash, mucocutaneous lesions, LAD
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" | <br>
| |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" | <br>
| |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" |
| |
| See CDC
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | <br>
| |
| |-
| |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" |
| |
| Latent Syphilis
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" |
| |
| Seroreactivity without other evidence of disease
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" |
| |
| ''Early''
| |
| | |
| ''Late''
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" |
| |
| Doxycycline 100mg po bid x 28d
| |
| | |
| Tetracycline 500mg po qid x 28d
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" |
| |
| See CDC
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | <br>
| |
| |-
| |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" |
| |
| Tertiary Syphilis
| |
| | |
| (''T. pallidum''<span style="font-style: normal">)</span>
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" |
| |
| Cardiac (aortitis), ophtho (iritis, uveitis), gumma
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" |
| |
| Benzathine<span> </span>Penicillin G 2.4million U IM qweek x 3
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" | <br>
| |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" |
| |
| See CDC
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | <br>
| |
| |-
| |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" |
| |
| Neurosyphilis
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" |
| |
| Meningitis, syphilitic eye disease
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" |
| |
| Aqueous crystalline penicillin G 18-24million units/d administered as 3-4million units IV q4h or continuous infusion x 10-14days
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" |
| |
| Procaine penicillin 2.4million units IM qday + Probenecid 500mg po qid<span> </span>
| |
| | |
| BOTH for 10-14d
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" | <br>
| |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | <br>
| |
| |-
| |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" |
| |
| HSV (1<sup>st</sup> episode)
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" |
| |
| Vesilcular rash
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" |
| |
| Acyclovir 400mg po TID x 7-10day
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" |
| |
| Famciclovir 250mg po TID x 7-10d
| |
| | |
| Valacyclovir 1g PO BID x 7-10d
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" | <br>
| |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | <br>
| |
| |-
| |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" |
| |
| HSV (suppressive)
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | <br>
| |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" |
| |
| Acyclovir 400mg PO BID
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" |
| |
| Famciclovir 250mg po BID
| |
| | |
| Valacyclovir 500mg PO qday
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" | <br>
| |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | <br>
| |
| |-
| |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" |
| |
| Epididymitis
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" |
| |
| Pain, swelling, inflammation of the epididymis
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" |
| |
| CTX 250mg IM + Doxycyline 100mg po bid x 10d
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" |
| |
| Oflox 300mg<span> </span>po bid x 10d + levoflox 500mg po qday x 10d
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" | <br>
| |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | <br>
| |
| |-
| |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" |
| |
| Epididymorchitis
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | <br>
| |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" | <br>
| |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" | <br>
| |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" | <br>
| |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | <br>
| |
| |-
| |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" |
| |
| Proctitis
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" |
| |
| Inflammation of the rectum (distal 10-12cm)
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" |
| |
| CTX 125mg IM x1 + Doxy 100mg po bid x 7d
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" | <br>
| |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" | <br>
| |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | <br>
| |
| |-
| |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" |
| |
| [[PID]] | |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" |
| |
| Sexually active, no other sources and: CMT OR uterine OR adnexal TTP
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" |
| |
| '''Outpt:'''
| |
| | |
| Ceftriaxone 250mg IM x1
| |
| | |
| OR
| |
| | |
| Cefoxitin 2g IM in a single dose and probenecid 1g orally administered concurrently in single dose
| |
| | |
| OR
| |
| | |
| Other parenteral 3<sup>rd</sup> gen cephalosporin eg ceftizoxime or cefotaxime
| |
| | |
| PLUS
| |
| | |
| Doxy 100mg po bid x14d
| |
| | |
| +/-
| |
| | |
| Metronidazole 500mg po bid x 14d
| |
| | |
| | |
| | |
| '''Inpt:'''
| |
| | |
| Cefotetan 2g IV q12h
| |
| | |
| OR
| |
| | |
| Cefoxitin 2g IV q6h
| |
| | |
| PLUS
| |
| | |
| Doxycyline 100mg IV or PO q12
| |
| | |
| (''similar bioavailability)'' | |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" |
| |
| '''Outpt:'''
| |
| | |
| Oflox 400mg po bid x 14d
| |
| | |
| OR
| |
| | |
| Levofloxacin 500mg po qday x 14d
| |
| | |
| +/-
| |
| | |
| Metronidazole 500mg po bid x 14d
| |
| | |
| | |
| | |
| '''Inpt:'''
| |
| | |
| Clinda 900mg IV q8h
| |
| | |
| PLUS
| |
| | |
| Gent load 2mgkg IV; maintenance 1.5mg/kg q8h; single daily dosing may be substituted
| |
| | |
| +/-
| |
| | |
| Metro 500mg IVq8h
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" | <br>
| |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | <br>
| |
| |-
| |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" |
| |
| Scabies
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" |
| |
| Crusted rash, intertiginous areas
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" |
| |
| Permethrin 5% cream applied to all areas of body from neck down and rinsed off after 8-14h
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" |
| |
| Ivermectin 200mcg/kg PO, repeated in 2weeks
| |
| | |
| Lindane (1%) 1 ounce of lotion of 30g of cream applied in thin layer all over from neck down x 8 hours then rinse
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" | <br>
| |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | <br>
| |
| |-
| |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" |
| |
| Pediculosis Pubis
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" |
| |
| Puritic genitalia
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" |
| |
| Permethrin 1% cream: apply to affected areas x 10mins then wash off
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" |
| |
| Malathion lotion 0.5% apply x 8-12h then rinse
| |
| | |
| OR
| |
| | |
| Ivermectin<span> </span>250mcg/kg PO repeated in 2 weeks
| |
| | |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" | <br>
| |
| | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | <br>
| |
| |}
| |
| | |
| †Test for HIV, syphilis
| |
|
| |
|
| ==See Also== | | ==See Also== |
| *[[Pelvic Inflmatory Disease (PID)]] | | *[[Human Papillomavirus (HPV)]] |
| | *[[Pelvic Inflammatory Disease (PID)]] |
| *[[Ulcerative STDs]] | | *[[Ulcerative STDs]] |
| | *[[Penile diagnoses]] |
| | *[[Pelvic pain]] |
| | *[[Expedited Partner Therapy]] |
|
| |
|
| == Source == | | ==References== |
| DeBonis
| | <references/> |
| | |
| Adapted from CDC 2010 Guidelines
| |
|
| |
|
| [[Category:GU]] [[Category:ID]] [[Category:OB/GYN]] | | [[Category:Urology]] [[Category:ID]] [[Category:OBGYN]] |